NCT04028557

Brief Summary

The objective of this proposal is to compare clinical outcomes, implementation metrics (i.e., patient reach and clinician adoption), and clinician preferences of two designs (customized vs. commercial) of a clinical decision support (CDS). Beta blocker prescribing for patients with heart failure will be used as a test case. The best practices in CDS design, including the user-centered design will be incorporated into the customized CDS and compared to a commercially-available CDS in the electronic health record using a cluster randomized trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
118

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 24, 2019

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

July 8, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 22, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 23, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 23, 2019

Completed
Last Updated

May 6, 2022

Status Verified

May 1, 2022

Enrollment Period

3 months

First QC Date

July 8, 2019

Last Update Submit

May 4, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in prescription of Beta blocker (BB)

    Number of prescriptions of an evidence based BB during a primary care office visit.

    6 months post CDS implementation

Secondary Outcomes (3)

  • Patient Reach

    6 months post CDS implementation

  • Clinician Adoption

    6 months post CDS implementation

  • Factors Influencing Clinician Adoption of the CDS per Qualitative Interviews

    6 months post CDS implementation

Study Arms (2)

Customized CDS

EXPERIMENTAL

The customized CDS will be designed and implemented with comprehensive application of known best practice principles in CDS design. The recommendation will be to initiate an evidence-based beta blocker for heart failure.

Other: Decision Support Systems, Clinical

Commercial CDS

ACTIVE COMPARATOR

The commercial CDS is available to all institutions using the Epic electronic health record vendor, but violates some CDS design best practices, notably not being tailored to the end users of a given health system. The recommendation will be to initiate an evidence-based beta blocker for heart failure.

Other: Decision Support Systems, Clinical

Interventions

Active computerized clinical decision support alert within the electronic health record that recommends initiation of an evidence-based beta blocker for heart failure and reduced ejection fraction.

Also known as: CDS
Commercial CDSCustomized CDS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Prescribing primary care clinicians at University of Colorado Health (UCHealth) who provide care for patients with heart failure and reduced ejection fraction

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Health

Aurora, Colorado, 80045, United States

Location

Related Publications (1)

  • Trinkley KE, Kroehl ME, Kahn MG, Allen LA, Bennett TD, Hale G, Haugen H, Heckman S, Kao DP, Kim J, Matlock DM, Malone DC, Page Nd RL, Stine J, Suresh K, Wells L, Lin CT. Applying Clinical Decision Support Design Best Practices With the Practical Robust Implementation and Sustainability Model Versus Reliance on Commercially Available Clinical Decision Support Tools: Randomized Controlled Trial. JMIR Med Inform. 2021 Mar 22;9(3):e24359. doi: 10.2196/24359.

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Katy E Trinkley, PharmD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2019

First Posted

July 22, 2019

Study Start

June 24, 2019

Primary Completion

September 23, 2019

Study Completion

September 23, 2019

Last Updated

May 6, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations